These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32946568)

  • 21. Changes in levels of T cell subpopulations to monitor the response to antiretroviral therapy among HIV-1-infected patients during two years of HIV-1 replication suppression.
    Zhang JC; Zhang HJ; Li Y; Jing D; Liu Q; Zhao K; Liu QQ; Zhuang Y; Kang WZ; Sun YT
    Scand J Infect Dis; 2013 May; 45(5):368-77. PubMed ID: 23186319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toll-Like Receptor 7 Agonist GS-9620 Induces HIV Expression and HIV-Specific Immunity in Cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy.
    Tsai A; Irrinki A; Kaur J; Cihlar T; Kukolj G; Sloan DD; Murry JP
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28179531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The evaluation of platelet indices and markers of inflammation, coagulation and disease progression in treatment-naïve, asymptomatic HIV-infected individuals.
    Nkambule BB; Davison GM; Ipp H
    Int J Lab Hematol; 2015 Aug; 37(4):450-8. PubMed ID: 25401263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short Communication: Expression of Host Restriction Factors by Memory CD4+ T Cells Differs Between Healthy Donors and HIV-1-Infected Individuals with Effective Antiretroviral Therapy.
    Bachtel ND; Beckerle GA; Mota TM; Rougvie MM; Raposo RAS; Jones RB; Nixon DF; Apps R
    AIDS Res Hum Retroviruses; 2019 Jan; 35(1):108-111. PubMed ID: 30198299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD4+ T-cell Count may not be a Useful Strategy to Monitor Antiretroviral Therapy Response in HTLV-1/HIV Co-infected Patients.
    Vandormael A; Rego F; Danaviah S; Carlos Junior Alcantara L; Boulware DR; de Oliveira T
    Curr HIV Res; 2017; 15(3):225-231. PubMed ID: 28215175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. After 18 months of antiretroviral therapy, total HIV DNA decreases more pronouncedly in patients infected by CRF01_AE than in those infected by subtype B and CRF07_BC.
    Lu Z; Jiao Y; Li J; Lan G; Lu C; Li X; Tang Z; Wang N
    Microbiol Immunol; 2018 Apr; 62(4):248-254. PubMed ID: 29377267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for extended age dependent maternal immunity in infected children: mother to child transmission of HIV infection and potential interventions including sulfatides of the human fetal adnexa and complementary or alternative medicines.
    Bhargav H; Huilgol V; Metri K; Sundell IB; Tripathi S; Ramagouda N; Jadhav M; Raghuram N; Ramarao NH; Koka PS
    J Stem Cells; 2012; 7(3):127-53. PubMed ID: 23619381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistent low viral load on antiretroviral therapy is associated with T cell-mediated control of HIV replication.
    Alatrakchi N; Duvivier C; Costagliola D; Samri A; Marcelin AG; Kamkamidze G; Astriti M; Agher R; Calvez V; Autran B; Katlama C
    AIDS; 2005 Jan; 19(1):25-33. PubMed ID: 15627030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does rapid HIV disease progression prior to combination antiretroviral therapy hinder optimal CD4+ T-cell recovery once HIV-1 suppression is achieved?
    Jarrin I; Pantazis N; Dalmau J; Phillips AN; Olson A; Mussini C; Boufassa F; Costagliola D; Porter K; Blanco J; Del Amo J; Martinez-Picado J;
    AIDS; 2015 Nov; 29(17):2323-33. PubMed ID: 26544704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A mature macrophage is a principal HIV-1 cellular reservoir in humanized mice after treatment with long acting antiretroviral therapy.
    Araínga M; Edagwa B; Mosley RL; Poluektova LY; Gorantla S; Gendelman HE
    Retrovirology; 2017 Mar; 14(1):17. PubMed ID: 28279181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between hepatitis C virus (HCV) and insulin resistance, endothelial perturbation, and platelet activation in HIV-HCV-coinfected patients under highly active antiretroviral treatment.
    de Larrañaga GF; Wingeyer SD; Puga LM; Alonso BS; Benetucci JA
    Eur J Clin Microbiol Infect Dis; 2006 Feb; 25(2):98-103. PubMed ID: 16477441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen.
    Waters L; Mandalia S; Randell P; Wildfire A; Gazzard B; Moyle G
    Clin Infect Dis; 2008 May; 46(10):1617-23. PubMed ID: 18419499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid development of HIV elite control in a patient with acute infection.
    Morley D; Lambert JS; Hogan LE; De Gascun C; Redmond N; Rutishauser RL; Thanh C; Gibson EA; Hobbs K; Bakkour S; Busch MP; Farrell J; McGetrick P; Henrich TJ
    BMC Infect Dis; 2019 Sep; 19(1):815. PubMed ID: 31533639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelets and erythrocyte-bound platelets bind infectious HIV-1 in plasma of chronically infected patients.
    Beck Z; Jagodzinski LL; Eller MA; Thelian D; Matyas GR; Kunz AN; Alving CR
    PLoS One; 2013; 8(11):e81002. PubMed ID: 24282562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD71
    Namdar A; Dunsmore G; Shahbaz S; Koleva P; Xu L; Jovel J; Houston S; Elahi S
    mBio; 2019 Nov; 10(6):. PubMed ID: 31772057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell-Associated HIV-1 Unspliced-to-Multiply-Spliced RNA Ratio at 12 Weeks of ART Predicts Immune Reconstitution on Therapy.
    Scherpenisse M; Kootstra NA; Bakker M; Berkhout B; Pasternak AO
    mBio; 2021 Mar; 12(2):. PubMed ID: 33688002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of polymorphisms in the HCP5 and HLA-C, and ZNRD1 genes on HIV viral load.
    Thørner LW; Erikstrup C; Harritshøj LH; Larsen MH; Kronborg G; Pedersen C; Larsen CS; Pedersen G; Gerstoft J; Obel N; Ullum H
    Infect Genet Evol; 2016 Jul; 41():185-190. PubMed ID: 27083073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
    Pierson T; McArthur J; Siliciano RF
    Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The CD4/CD8 ratio in HIV-infected subjects is independently associated with T-cell activation despite long-term viral suppression.
    Serrano-Villar S; Gutiérrez C; Vallejo A; Hernández-Novoa B; Díaz L; Abad Fernández M; Madrid N; Dronda F; Zamora J; Muñoz-Fernández MÁ; Moreno S
    J Infect; 2013 Jan; 66(1):57-66. PubMed ID: 23046968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Parameters of the CD4-Cell count and viral load in human immunodeficiency virus type 1 (HIV-1) infected patients].
    Selimova LM; Serebrovskaya LV; Ivanova LA; Kravchenko AV; Buravtsova EV
    Vopr Virusol; 2015; 60(2):31-4. PubMed ID: 26182654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.